Covid cases across England are 13 times higher in young people compared to the over-60s, according to official figures which highlight the ‘vaccine effect’ on... Read More
AstraZeneca
A SAGE scientist has admitted the Covid modelling that spooked No10 into delaying ‘Freedom Day’ last month underestimated the power of vaccines. Dr Mike Tildesley... Read More
Doctors report first known case of rare blood clots in US patient who received Moderna COVID vaccine
3 min read
Doctors report first known case of rare blood clots in US patient who received Moderna COVID vaccine
Doctors have documented what they believe to be the first known case of a U.S. patient developing blood clots after receiving the Moderna COVID-19 vaccine.... Read More
Booster Covid jabs are NOT needed this winter because immunity lasts so long, study finds
7 min read
Professor Sir Andrew Pollard said there is ‘no indication at the moment that we need boosters’, despite his study showing that the third jab gave... Read More
Mixing and matching Covid vaccines may result in higher protection against the virus, a UK Government-backed study has found. People who had been vaccinated with... Read More
Four Brits develop Guillain-Barré syndrome just days after having AstraZeneca’s Covid jab
4 min read
Four British men have developed a potentially life-threatening condition just days after having AstraZeneca‘s Covid vaccine. The recipients developed Guillain-Barré syndrome, which can cause paralysis... Read More
Nearly 4,000 women have suffered period problems shortly after getting their Covid jab, Britain’s vaccines watchdog has confirmed. The issues, which have typically involved ‘heavier... Read More
SAGE‘s Covid death predictions may be downgraded by tens of thousands because the vaccines are performing better than expected against the Indian variant and the... Read More
Professor Pollard said there is no evidence that vaccine protection is reducing, so it is not yet clear whether a booster jab is needed Coronavirus... Read More
AstraZeneca AZN -0.27% PLC’s coronavirus antibody treatment failed in late-stage clinical trials to achieve its primary goal of preventing symptomatic Covid-19 in people recently exposed... Read More
